One year ago, ASCO was engaged in an all too familiar exercise: working around the clock to prevent scheduled cuts in Medicare physician payments. If implemented, these cuts would have reduced access to care for many older and disabled Americans. Congress responded with another patch, or temporary fix to avert the harmful cuts.
This has been a steady pattern since 2002, as Congress has had to step in numerous times to avert cuts resulting from the Sustainable Growth Rate—a formula that severely underestimates the costs of treating Medicare patients. Unless Congress steps in again, the formula will result in a 27.4 percent cut to reimbursement rates for 2012. President Obama has proposed to freeze payments at 2011 levels for two years to allow for development of a permanent fix.
A significant cut to Medicare payments as a result of the SGR would create barriers to care for cancer patients by forcing many community-based oncology practices—already grappling with previous Medicare cuts and increased administrative burdens—to limit their services or close altogether.
Read the full article at: http://tinyurl.com/7538yg8
Source: ASCO
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Combatting Misconceptions of Clinical Trials to Improve Patient Participation
October 16th 2024There are many misconceptions patients might have about clinical trials that prevent them from participating, and it’s important to understand what they are in order to overcome them, said Terry L. Keys, of University of Kentucky Markey Cancer Center.
Read More
Creating Equitable Cancer Care for Americans of Asian and Pacific Islander Heritage
October 15th 2024Naoto T. Ueno, MD, PhD, FACP, of the University of Hawai’I Cancer Center outlines the underrepresentation in clinical trials, the lack of permanent medical oncologists, and issues of trust affecting care for the populations living in Hawaii.
Read More